EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineering a Microfluidic Platform to Cryopreserve Stem Cells: A DMSO‐Free Sustainable Approach

Saman Modaresi, Settimio Pacelli, Aishik Chakraborty, Ali Coyle, Wei Luo, Irtisha Singh, Arghya Paul iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202401264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Saman Modaresi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Petroleum Engineering, Bioengineering Graduate Program, School of Engineering, The University of Kansas, Lawrence, KS, 660…. Hauptthemen laut MEDLINE: Cryopreservation, Trehalose, Stem Cells, Dimethyl Sulfoxide. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Frontiers in Research Fund (NFRF) - Exploration Stream, NINDS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human adipose‐derived stem cells (hASCs) are cryopreserved traditionally using dimethyl sulfoxide (DMSO) as the cryoprotectant agent. DMSO penetrates cell membranes and prevents cellular damage during cryopreservation. However, DMSO is not inert to cells, inducing cytotoxic effects by causing mitochondrial dysfunction, reduced cell proliferation, and impaired hASCs transplantation. Additionally, large‐scale production of DMSO and contamination can adversely impact the environment. A sustainable, green alternative to DMSO is trehalose, a natural disaccharide cryoprotectant agent that does not pose any risk of cytotoxicity. However, the cellular permeability of trehalose is less compared to DMSO. Here, a microfluidic chip is developed for the intracellular delivery of trehalose in hASCs. The chip is designed for mechanoporation, which creates transient pores in cell membranes by mechanical deformation. Mechanoporation allows the sparingly permeable trehalose to be internalized within the cell cytosol. The amount of trehalose delivered intracellularly is quantified and optimized based on cellular compatibility and functionality. Furthermore, whole‐transcriptome sequencing confirms that less than 1% of all target genes display at least a twofold change in expression when cells are passed through the chip compared to untreated cells. Overall, the results confirm the feasibility and effectiveness of using this microfluidic chip for DMSO‐free cryopreservation of hASCs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryopreservationTrehaloseStem CellsDimethyl SulfoxideCryoprotective AgentsHumansLab-On-A-Chip DevicesAdipose TissueMicrofluidics

Stichwörter der Autor:innen

DMSO‐free cell bankingcryopreservationmechanoporationmicrofabricated chipmicrofluidicsstem cell freezingtrehalose delivery

Substanzen

TrehaloseDimethyl SulfoxideCryoprotective Agents

Autor:innen und Institutionen

  • Department of Chemical and Petroleum Engineering, Bioengineering Graduate Program, School of Engineering, The University of Kansas, Lawrence, KS, 66045, USA.
  • Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, 60616, USA.
  • Department of Chemical and Biochemical Engineering, The University of Western Ontario, London, ON, N6A 5B9, Canada.
  • Collaborative Specialization in Musculoskeletal Health Research and Bone and Joint Institute, The University of Western Ontario, London, ON, N6A 5B9, Canada.
  • School of Biomedical Engineering, The University of Western Ontario, London, ON, N6A 5B9, Canada.
  • Department of Cell Biology and Genetics, College of Medicine, Texas A&M University, Bryan, TX, 77807, USA.

ORCID-Profile: Arghya Paul

Förderung

  • New Frontiers in Research Fund (NFRF) - Exploration Stream
  • NINDS NIH HHS
  • NCI NIH HHS
  • CIHR
  • Natural Sciences and Engineering Research Council (NSERC) of Canada
  • NIDCR NIH HHS
  • Canadian Institutes of Health Research

Zitieren

APA

Modaresi, S., Pacelli, S., Chakraborty, A., Coyle, A., Luo, W., Singh, I., & Paul, A. (2024). Engineering a Microfluidic Platform to Cryopreserve Stem Cells: A DMSO‐Free Sustainable Approach. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401264

Vancouver

Modaresi S, Pacelli S, Chakraborty A, Coyle A, Luo W, Singh I, et al. Engineering a Microfluidic Platform to Cryopreserve Stem Cells: A DMSO‐Free Sustainable Approach. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401264

BibTeX
@article{Modaresi2024,
  author = {Modaresi, Saman and Pacelli, Settimio and Chakraborty, Aishik and Coyle, Ali and Luo, Wei and Singh, Irtisha and Paul, Arghya},
  title = {Engineering a Microfluidic Platform to Cryopreserve Stem Cells: A DMSO‐Free Sustainable Approach},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202401264}
}
Kostenlos starten →